The European Commission has initiated an investigation into China’s alleged discriminatory practices in medical device tenders, which have hindered European companies from competing fairly in the Chinese market. The probe aims to determine the existence of these practices and, if confirmed, could lead to retaliatory measures by the EU. This move is the first of its kind under the International Procurement Instrument, reflecting the bloc’s efforts to combat unfair competition from China, which has employed various measures to favor domestic companies over foreign rivals.
